Pietro Leone

Dr. Pietro Leone

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2012 in Orthodontics & Craniofacial Research
Verified
Journal Article
Closed access
PDF file
RMR. Martina
R. Martina
ICI. Cioffi
I. Cioffi
MFM. Farella
M. Farella
Pietro LeonePietro Leone
Pietro Leone
PMP. Manzo
P. Manzo
GCG. Cordasco
G. Cordasco

1 November 2012 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
GCGiancarlo Cordasco
Giancarlo Cordasco
Riccardo NuceraRiccardo Nucera
Riccardo Nucera
RFRosamaria Fastuca
Rosamaria Fastuca
Giovanni MatareseGiovanni Matarese
Giovanni Matarese
SLSteven J. Lindauer
Steven J. Lindauer
RMRoberto Martina
Roberto Martina

20 November 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
LGLata Goyal
Lata Goyal
MGMehak Gupta
Mehak Gupta
SSShubham Sareen
Shubham Sareen
NANur Rahman Ahmad Seno Aji
Nur Rahman Ahmad Seno Aji
VSVaibhav Sahni
Vaibhav Sahni
Pietro LeonePietro Leone
Pietro Leone
Background/Objectives : Periodontitis is a chronic inflammatory disease initiated by dysbiotic biofilms and driven by host immune dysregulation, leading to connective tissue destruction and alveolar bone loss. Its early diagnosis is closely linked to the progression and outcome of the disease. Active-matrix metalloproteinase-8 (aMMP-8) is one of the key biomarkers for estimating irreversible collagenolytic degradation. aMMP-8 is among the key biomarkers for estimating irreversible collagenolytic degradation. To evaluate the role of oral fluid/salivary/mouthrinse aMMP-8 tests for early detection and treatment monitoring of periodontitis. Methods: A search was conducted in the Medline, Embase, Scopus, and Cochrane databases, restricted to articles published between January 2020 and December 2024 to capture the most recent literature. Pilot, cohort, case–control, and cross-sectional studies were included, while studies not aligning with the objectives of this review, as well as narrative reviews, editorials, and opinions were excluded. Results: A total of 276 articles were retrieved. After removing duplicates, 226 studies remained, of which 216 were retained following title, abstract, and keyword screening. From these, 26 studies were finally included in this review. aMMP-8 point-of-care tests appear to be promising tools for early diagnosis, disease severity assessment, and treatment monitoring in periodontitis, though findings remain conflicting across studies. Elevated aMMP-8 levels are associated with active periodontal pathology and tissue destruction, reflecting ongoing collagenolytic degeneration. Conclusions: aMMP-8 mouthrinse, saliva, or oral fluid tests can be used for predictive and early diagnosis as well as for treatment monitoring in patients with periodontal disease, and they function effectively as biomarkers for periodontitis.

20 January 2026 in Journal of Periodontal Research
Verified
Journal Article
Open access
TSTimo Sorsa
Timo Sorsa
LGLorne M. Golub
Lorne M. Golub
JTJulie Toby
Julie Toby
Pietro LeonePietro Leone
Pietro Leone
Sukumaran AnilSukumaran Anil
Sukumaran Anil
VUVeli‐Jukka Uitto
Veli‐Jukka Uitto
Matrix metalloproteinases (MMPs) represent a family of 23 zinc‐dependent endopeptidases central to extracellular matrix remodeling in periodontal and peri‐implant diseases. This comprehensive review examines the pathogenic mechanisms, diagnostic applications, and therapeutic targeting potential of the entire MMP family in periodontitis and peri‐implantitis. All MMP subfamilies, collagenases (MMP‐1, ‐8, ‐13), gelatinases (MMP‐2, ‐9), stromelysins (MMP‐3, ‐10, ‐11), matrilysins (MMP‐7, ‐26), membrane‐type MMPs (MT1‐6), and others, demonstrate distinct expression patterns and substrate specificities in diseased tissues. MMP‐8 and MMP‐9 emerge as primary biomarkers, showing 5–6‐fold elevations in active periodontitis compared to health, with corresponding increases in activation ratios and decreases in tissue inhibitor of metalloproteinase (TIMP) levels. Diagnostic applications reveal point‐of‐care active MMP‐8 (aMMP‐8) immunotests achieve 70%–85% sensitivity and 65%–80% specificity for periodontitis detection, though standardization challenges limit clinical implementation. Salivary and gingival crevicular fluid MMP profiling demonstrates disease‐specific signatures, with MMP‐8/TIMP‐1 ratios serving as progression indicators. Therapeutically, MMP modulation strategies include FDA‐approved subantimicrobial dose doxycycline (SDD), which achieves a 40%–60% reduction in clinical attachment loss. Novel approaches encompass selective MMP inhibitors, pro‐resolving mediators, and host‐modulation therapies, with emerging AI‐assisted personalized treatment protocols showing promise. Critically, peri‐implantitis exhibits more severe MMP dysregulation than periodontitis, with MMP: TIMP ratios reaching 50:1 versus 20:1, accelerated bone loss patterns, and distinct MT‐MMP involvement reflecting titanium surface interactions. Translation barriers include the need for biomarker standardization, the complexity of MMP redundancy, and the requirement for personalized diagnostic thresholds. Future directions emphasize integrating MMP signatures with multi‐omics approaches, developing selective inhibitors, and establishing evidence‐based clinical guidelines for MMP‐targeted precision periodontal medicine.

1 January 2026 in International Journal of Dentistry
Verified
Journal Article
Open access
PDF file
Pietro LeonePietro Leone
Pietro Leone
JTJulie Toby
Julie Toby
TSTimo Sorsa
Timo Sorsa
MKMauno Könönen
Mauno Könönen
Sukumaran AnilSukumaran Anil
Sukumaran Anil
Background: Occlusal trauma has long been debated as a contributing factor in periodontitis. Excessive occlusal loading acting on inflamed tissues may accelerate periodontal breakdown through inflammatory and proteolytic pathways. This scoping review synthesizes current evidence from clinical, animal, and in vitro studies on the mechanistic and clinical interplay between occlusal trauma and periodontal degradation. Methods: In accordance with Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for scoping reviews (PRISMA‐ScR), PubMed, Web of Science, Scopus, Embase, and Cochrane Library were searched for studies published 2014–2025. Clinical trials, observational studies, animal models, and in‐vitro experiments evaluating occlusal loading in periodontitis were eligible. Study selection followed the PECO framework and targeted inflammatory mediators, aMMP‐8 activity, and clinical periodontal outcomes. Results: Eighteen studies met the inclusion criteria: eight clinical, seven animal, and three in vitro. Clinical studies have reported that occlusal adjustment, when combined with periodontal therapy, yields greater reductions in probing depth (PD), bleeding on probing (BoP), and pathogenic bacterial load compared to periodontal therapy alone. Animal and in vitro studies consistently demonstrate that mechanical loading amplifies inflammatory cytokine production (e.g., interleukin [IL]‐6 and TNF‐α), activates signaling pathways (inhibitor of kappa B kinase/nuclear factor kappa [IKK/NF‐κB] and yes‐associated protein [YAP]), and suppresses osteogenic differentiation. The release of matrix metalloproteinases (MMPs), particularly MMP‐8, was a recurring feature associated with collagen degradation. Conclusions: Occlusal trauma functions as a modifying factor that may exacerbate periodontitis progression in susceptible individuals, though it should not be considered an initiating cause of disease. The integration of occlusal assessment, active MMP‐8 (aMMP‐8) biomarker analysis, and targeted therapies may enhance periodontal treatment outcomes. However, the modest effect sizes observed in clinical studies suggest that selective rather than routine occlusal intervention may optimize the benefit‐to‐burden ratio. Further longitudinal and interventional studies are warranted to validate these findings and establish clinical guidelines.

6 May 2026 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
NANur Rahman Ahmad Seno Aji
Nur Rahman Ahmad Seno Aji
SASebastian Ahlstrand
Sebastian Ahlstrand
VSVaibhav Sahni
Vaibhav Sahni
KTKartika Widayati Taroeno-Hariadi
Kartika Widayati Taroeno-Hariadi
DLDyah Listyarifah
Dyah Listyarifah
TSTimo Sorsa
Timo Sorsa
Objectives: To investigate whether Porphyromonas gingivalis gingipains contribute to the activation of MMP-8 and MMP-9 in patients with cancer and to evaluate the potential of aMMP-8 chair-side test for early detection of active periodontal inflammation in cancer care. Methods: This cross-sectional study enrolled 89 of 119 initially assessed patients with cancer at Dr. Sardjito Hospital, Yogyakarta, Indonesia (2023–2024). Active MMP-8 was quantified using a chair-side test on oral rinse samples. Total MMP-8 was measured by ELISA, MMP-9 activation by gelatin zymography, and gingipain presence by Western immunoblotting. Associations with periodontal parameters (PPD, GI, OHI-S, and VPI) were analyzed using linear regression. Results: aMMP-8 chair-side test demonstrated 91% positive results in 89 patients with cancer. Western blotting revealed the co-localization of gingipains with fragmented MMP-8. aMMP-8 levels were significantly associated with MMP-9 activation (p = 0.003, R2 = 0.097), suggesting proteolytic cascade activation. Oral hygiene indices showed stronger associations (OHI-S: p = 0.003, R2 = 0.100; VPI: p = 0.014, R2 = 0.067) than deeper periodontal parameters (PPD: p = 0.094; GI: p = 0.358), suggesting early-stage inflammation detection. Conclusions: Gingipain presence may be associated with the activation of MMP-8 and MMP-9 in patients with cancer, which links bacterial virulence to amplified tissue destruction. aMMP-8 chair-side test enables rapid identification of active inflammation, facilitating timely periodontal intervention during cancer care.